Influence of bacterial resistance on mortality in intensive care units: a registry study from 2000 to 2013 (IICU Study)☆
Introduction
As a cause of multi-organ failure in septic shock, or a precipitating event over the course of severe illness, infection is an independent risk factor of mortality in intensive care units (ICUs) and thus a daily concern. Furthermore, healthcare-associated infections have substantial effects on morbidity and length of hospital stay and represent a major public health issue [1], [2], [3], [4]. Consequently, wide international prevention programmes have been implemented to specifically target these infections [5]. However, despite these efforts, the nosocomial infection incidence seems to be rising [1], [6].
The problem is compounded by bacterial resistance to antibiotics, leading to delays in appropriate antibiotic therapy and raising the question of a possible overmortality [1], [7]. Indeed, ICU patients are not only extremely vulnerable but also the most prone to infections related to resistant bacteria as a result of antibiotic misuse or overuse, long hospitalizations, and the rapid spread of resistant strains from abroad [8], [9], [10], [11], [12]. Improvements in infection management tend to focus on antibiotic resistance, as reflected by recent national campaigns in many countries [13], [14].
Thus, surveillance and control networks have been implemented worldwide, such as the US Centers for Disease Control and Prevention or the Centres de Coordination de la Lutte contre les Infections Nosocomiales (CCLIN) in France. The latter prospectively includes demographic, bacteriological, and clinical data from a wide representative sample of ICUs.
However, only sparse data are available concerning the role of bacterial resistance, and conflicting evidence exists concerning its impact on mortality: a recent literature review reported studies in which resistant bacterial strains were associated with increased mortality and many others in which mortality was independent of antibiotic resistance [15], [16], [17].
Consequently, the aim of this study was to compare the mortality of hospital-acquired infections with respect to bacterial resistance to antibiotics over an extended period of 13 years in 29 French ICUs in the CCLIN Network. We hypothesized that patients with infections with resistant bacteria in ICU are associated with increased mortality rate and longer hospital stays than those with susceptible strains.
Section snippets
Ethics, consent, and permissions
Following institutional review board agreement (Ethics Committee for Research in Anesthesiology and Intensive Care, French Society of Anesthesiology and Intensive Care, 74 rue Raynouard, 75016 Paris, France; Ref. IRB 00010254-2016-119), prospective data were collected from 2000 to 2013 from a database involving 29 French ICUs included in a specific network aimed at studying hospital-acquired infections (Centres de Coordination de la Lutte contre les Infections Nosocomiales Ouest: CCLIN Ouest)
Entire cohort
From 2000 to 2013, data from 87,931 patients were collected, including 10,001 with a hospital-acquired infection. There were 8428 cases with an identified pathogen, 1121 cases without a pathogen being detected, and 428 cases with missing data). The primary patient demographics and characteristics are reported in Table I. Multivariate analysis on the entire population identified SAPS II score (odds ratio: 1.24, 95% confidence interval (CI): 1.20–1.29), immunodepression (1.14; 1.05–1.23), trauma
Discussion
The present study shows that patients with infections are associated with increased mortality in ICU. Among infected patients, Gram-negative bacilli were responsible for a higher mortality and longer survivor-LOS than were Gram-positive cocci. Patients with bacterial resistance were associated with increased mortality and longer ICU survivor-LOS.
Sepsis is a known risk factor for ICU mortality, yet the impact of antibiotic resistance on mortality has been debated [1], [16], [17]. Among
Conflict of interest statement
None declared.
Funding sources
None.
References (40)
- et al.
Estimating the impact of healthcare-associated infections on length of stay and costs
Clin Microbiol Infect
(2010) - et al.
The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities
Am J Infect Control
(2008) - et al.
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units
Am J Infect Control
(2014) - et al.
Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit
J Infect
(2015) - et al.
Guidelines for the prevention of intravascular catheter-related infections
Am J Infect Control
(2011) - et al.
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Am J Infect Control
(2008) - et al.
Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study
Lancet Infect Dis
(2011) - et al.
International study of the prevalence and outcomes of infection in intensive care units
JAMA
(2009) - et al.
Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE
Crit Care
(2016) Economic burden of healthcare-associated infections: an American perspective
Expert Rev Pharmacoecon Outcomes Res
(2009)
The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee
JAMA
Antibiotic strategies in the era of multidrug resistance
Crit Care
Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients
Antimicrob Agents Chemother
Antibiotic stewardship in the intensive care unit
Crit Care
The antibiotic alarm
Nature
Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread
J Travel Med
Unwanted souvenirs: travel and multi-resistant bacteria
J Travel Med
National action plan for combating antibiotic-resistant bacteria
Première réunion du Comité interministériel pour la santé: maîtriser la résistance bactérienne aux antibiotiques
Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients
World J Crit Care Med
Cited by (0)
- ☆
This work is dedicated to the late Dr Nadine Garreau.